Asymmetric Unit (4, 11)
No. | Name | Count | Type | Full Name |
1 | C2E | 2 | Ligand/Ion | 9,9'-[(2R,3R,3AS,5S,7AR,9R,10R,10AS,12S,14AR)-3,5,10,12-TETRAHYDROXY-5,12-DIOXIDOOCTAHYDRO-2H,7H-DIFURO[3,2-D:3',2'-J][1,3,7,9,2,8]TETRAOXADIPHOSPHACYCLODODECINE-2,9-DIYL]BIS(2-AMINO-1,9-DIHYDRO-6H-PURIN-6-ONE) |
2 | GDP | 2 | Ligand/Ion | GUANOSINE-5'-DIPHOSPHATE |
3 | K | 2 | Ligand/Ion | POTASSIUM ION |
4 | MG | 5 | Ligand/Ion | MAGNESIUM ION |
Biological Unit 1 (2, 2)
No. | Name | Count | Type | Full Name |
1 | C2E | 1 | Ligand/Ion | 9,9'-[(2R,3R,3AS,5S,7AR,9R,10R,10AS,12S,14AR)-3,5,10,12-TETRAHYDROXY-5,12-DIOXIDOOCTAHYDRO-2H,7H-DIFURO[3,2-D:3',2'-J][1,3,7,9,2,8]TETRAOXADIPHOSPHACYCLODODECINE-2,9-DIYL]BIS(2-AMINO-1,9-DIHYDRO-6H-PURIN-6-ONE) |
2 | GDP | 1 | Ligand/Ion | GUANOSINE-5'-DIPHOSPHATE |
3 | K | -1 | Ligand/Ion | POTASSIUM ION |
4 | MG | -1 | Ligand/Ion | MAGNESIUM ION |
Biological Unit 2 (2, 2)
No. | Name | Count | Type | Full Name |
1 | C2E | 1 | Ligand/Ion | 9,9'-[(2R,3R,3AS,5S,7AR,9R,10R,10AS,12S,14AR)-3,5,10,12-TETRAHYDROXY-5,12-DIOXIDOOCTAHYDRO-2H,7H-DIFURO[3,2-D:3',2'-J][1,3,7,9,2,8]TETRAOXADIPHOSPHACYCLODODECINE-2,9-DIYL]BIS(2-AMINO-1,9-DIHYDRO-6H-PURIN-6-ONE) |
2 | GDP | 1 | Ligand/Ion | GUANOSINE-5'-DIPHOSPHATE |
3 | K | -1 | Ligand/Ion | POTASSIUM ION |
4 | MG | -1 | Ligand/Ion | MAGNESIUM ION |
|